News

Gastric Banding Reoperation Often Needed


 

SAN DIEGO — Thirteen percent of patients who underwent laparoscopic adjustable gastric banding required a major reoperation, results from a long-term, single-center study showed.

“We see complications, even many years after surgery,” Dr. Vincenzo Bacci said at the annual meeting of the American Society for Bariatric Surgery. “This information should really be conveyed to our surgical candidates. Lifelong management and surveillance are necessary for these patients.”

He and his associates studied the rate and causes of reoperation in 448 patients who underwent laparoscopic adjustable gastric banding at La Sapienza University in Rome, between 1996 and 2006. In 2002 the perigastric technique was replaced by the pars flaccida approach. Of the 448 patients, 83% were women; their average body mass index was 43 kg/m

Dr. Bacci reported that 59 patients (13%) required a major reoperation for band repositioning/removal or revision, and 29 patients (6%) required a minor reoperation for port complications. The rate of major reoperation was 4.1 per 100 person-years, while the rate of minor reoperation was 2.1 per 100 person-years.

Patients with a BMI of greater than 50 kg/m

Recommended Reading

Nuts, Popcorn Found OK For Diverticulosis Patients
MDedge Internal Medicine
Antioxidants Ease Pain in Chronic Pancreatitis Patients
MDedge Internal Medicine
Rosiglitazone May Curb Ulcerative Colitis Activity : In a study of 105 patients, 44% of those taking Avandia had clinical remission, vs. 23% on placebo.
MDedge Internal Medicine
Surveillance Intervals After Polypectomy Should Be Narrowed
MDedge Internal Medicine
Standard Hepatitis C Treatment Highly Effective
MDedge Internal Medicine
Serum Markers May Help Diagnose Nonalcoholic Fatty Liver
MDedge Internal Medicine
PillCam Shows Promise for Colorectal Screening
MDedge Internal Medicine
Aspirin's Chemopreventive Effects Seen 10 Years After Tx Initiation
MDedge Internal Medicine
Aspirin May Reduce Risk of Certain Colorectal Cancers
MDedge Internal Medicine
IBS Drug Pipeline Offers Some Promise
MDedge Internal Medicine